Digital Sponsored Clinical trials at the core: Decentralised, AI targeted, ESG... For Inventus' Steve Sanghera and Jim Michel 2025 was a year of progress in clinical trial enablement.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.